3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Recruiting
3
Unknown
1
Terminated
1
Suspended
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Gynecologic
2
Gastrointestinal
2
CNS
2
Thoracic
1
Other solid neoplasm
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Classical hematology
1
Breast
1
Conditions
Wilms Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Hepatic Veno-Occlusive Disease
1
Interventions
Docetaxel
33
Radiosurgery
22
Radiotherapy
21
Sunitinib
20
pembrolizumab
17
Gemcitabine
16
Cisplatin
16
Androgen Antagonists
15
enzalutamide
13
Nivolumab
13
Goserelin
12
Blood Specimen Collection
12
aldesleukin
11
Surveys and Questionnaires
11
Prednisone
11
Leuprolide
11
Cyclophosphamide
11
Abiraterone Acetate
11
Bevacizumab
10
bicalutamide
9
Multiparametric Magnetic Resonance Imaging
9
Carboplatin
9
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
8
Gonadotropin-Releasing Hormone
8
Filgrastim
8
Epirubicin
8
Chemotherapy, Adjuvant
8
Brachytherapy
8
toripalimab
7
tislelizumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Genetic Testing
×
Genitourinary
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled